Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post Marketing Clinical Follow-up, Randomised, Double-blind Study Comparing the Efficacy and Tolerability of Topical Rossoseq™ With Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)

NCT01666509 is registered in ClinicalTrials.gov with PBB Entrepreneur Ltd. as lead sponsor.

NCT NCT01666509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01666509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post Marketing Clinical Follow-up, Randomised, Double-blind Study Comparing the Efficacy and Tolerability of Topical Rossoseq™ With Vehicle in Rosacea Subtype 1 (Erythematotelangiectatic)
Lead sponsor
PBB Entrepreneur Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
December 31, 2012
Enrollment
61 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

rosacea subtype 1 (erythematotelangiectatic)